Tina Marriott Larson serves as Executive at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Tina Marriott Larson has executed 58 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 25, 2024 involved selling 8,000 shares valued at $82.8K.
Tina Marriott Larson currently holds 414,548 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tina Marriott Larson has been a net seller of RXRX stock. They have purchased $0 and sold $1.4M worth of shares.
Tina Marriott Larson's most recent insider trade was on Jan 25, 2024, when they sold 8,000 shares at $10.35 per share.
Get notified when new Form 4 filings are submitted
| $1.06 |
| Planned |
| Dec 28, 2023 | RXRX | $8.5K | Option Exercise | 8,000 | $1.06 | Planned |
| Dec 28, 2023 | RXRX | $84.6K | Sale | 8,000 | $10.58 | Planned |
| Nov 16, 2023 | RXRX | $3.2K | Option Exercise | 3,000 | $1.06 | Planned |
| Nov 16, 2023 | RXRX | $20.3K | Sale | 3,000 | $6.76 | Planned |
| Nov 15, 2023 | RXRX | $38.6K | Payment | 5,378 | $7.18 | Planned |
| Oct 26, 2023 | RXRX | $16.9K | Sale | 3,000 | $5.63 | Planned |
| Oct 26, 2023 | RXRX | $3.2K | Option Exercise | 3,000 | $1.06 | Planned |
| Sep 28, 2023 | RXRX | $3.2K | Option Exercise | 3,000 | $1.06 | Planned |
| Sep 28, 2023 | RXRX | $23.2K | Sale | 3,000 | $7.72 | Planned |
| Aug 24, 2023 | RXRX | $3.2K | Option Exercise | 3,000 | $1.06 | Planned |
| Aug 24, 2023 | RXRX | $25.4K | Sale | 2,937 | $8.64 | Planned |
| Aug 24, 2023 | RXRX | $595 | Sale | 63 | $9.45 | Planned |
| Aug 15, 2023 | RXRX | $49.4K | Payment | 5,378 | $9.18 | Planned |
| Jul 27, 2023 | RXRX | $61.4K | Sale | 4,373 | $14.05 | Planned |
| Jul 27, 2023 | RXRX | $8.5K | Option Exercise | 8,000 | $1.06 | Planned |
| Jul 27, 2023 | RXRX | $47.6K | Sale | 3,627 | $13.12 | Planned |
| Jun 29, 2023 | RXRX | $3.2K | Option Exercise | 3,000 | $1.06 | Planned |
| Jun 29, 2023 | RXRX | $22.5K | Sale | 3,000 | $7.49 | Planned |
| May 31, 2023 | RXRX | $3.2K | Option Exercise | 3,000 | $1.06 | Discretionary |
| May 31, 2023 | RXRX | $25.9K | Sale | 3,000 | $8.63 | Discretionary |
| May 15, 2023 | RXRX | $30.3K | Payment | 5,415 | $5.60 | Discretionary |
| Feb 23, 2023 | RXRX | $8.5K | Option Exercise | 8,000 | $1.06 | Discretionary |
| Feb 23, 2023 | RXRX | $62.6K | Sale | 8,000 | $7.82 | Discretionary |
| Feb 15, 2023 | RXRX | $13.5K | Payment | 1,603 | $8.44 | Discretionary |
| Feb 1, 2023 | RXRX | $26.4K | Payment | 3,093 | $8.55 | Discretionary |
| Feb 1, 2023 | RXRX | $0 | Award | 217,061 | $N/A | Discretionary |
| Feb 1, 2023 | RXRX | $0 | Award | 9,732 | $N/A | Discretionary |
| Jan 26, 2023 | RXRX | $8.5K | Option Exercise | 8,000 | $1.06 | Discretionary |